Adults over 60 years of age who will have an allogeneic stem cell transplant to treat their blood cancer are invited to be in a research study

IRB/UVA Tracking #
Principal Investigator
Tamila L Kindwall-Keller
Gianna Strand
Contact Email
Contact Phone
Official Trial Title
Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation in Older Adults
Study Description

The University of Virginia is conducting a clinical research study for adults ages 60 and over, who were offered an allogeneic stem cell transplant (transplant) to treat their blood cancer. The purpose of this study is to learn how well patients do after transplant, based on their health before transplant.

Participation in the study is approximately 1 year. This will include a physical test (e.g. grip strength and speed walking) and a test of your thinking, including your memory, attention and language skills before the transplant. Within 1 year after transplant, you will take the physical tests 3 more times and the test of your thinking one more time. You will take the tests in the hospital or clinic.

Study-related procedures that are being done beyond your standard of care will be provided at no cost to your or your insurance.

Additional information can be found here: